FIELD: organic chemistry, heterocyclic compounds. SUBSTANCE: invention relates to pyrazolopyrimidines of the general formula (I) and their pharmaceutically acceptable salts where A - a group NR1R2 or CR1
1
R1
2
R11; R1 - H or C1-C6-alkyl that can be free or substituted with some substituents, for example, OH, F, Cl and other, or C2-C6--alkenyl, or C2-C6--alkynyl; R2 is C1-C6-alkyl that can be free or substituted with some substituents, for example, OH, C1-C6-alkoxy and other; or C2-C6--alkenyl or C2-C6--alkynyl or furanyl; ((C1-C4--alkylene)-phenyl that can be substituted with 1 to 3 substituents: Cl, F, C1-C4--alkyl and a single substituent: C1-C6--alkoxy, CF3, NO2, NH2; or ((C1-C4)-alkylene)-heteryl where heteryl - thienyl possibly substituted with Cl, benzothienyl, pyridyl, quinolinyl, furanyl, benzofuranyl, thiazolyl, benzothiazolyl, pyrrolyl, pyrrolidinyl, 1-benzylpiperidinyl, tetrahydropyranyl; or ((C1-C4--alkylene)-cyclopropyl; or NR1R2 form heteryl taken from a group involving pyrrolinyl possibly substituted with benzyl, pyrrolidinyl possibly substituted with benzyl of OH, pyrrolyl, imidazolyl, thiazolidinyl, thiomorpholinyl; R1
1
- hydrogen, C1-C6--alkyl; R1
2
is C1-C6--alkyl; R3 - hydrogen, C1-C6--alkyl, O-((C1-C6--alkyl), S-((C1-C4--alkyl); R4 is C1-C6--alkyl or S-(O)n(C1-C6)-alkyl where n = 0-2; R5 is 2,4,6-substituted phenyl with Cl, C1-C6-alkyl, CF3; R11/ - H, OH, or COO-((C1-C2-alkyl) at condition that a group CR1
1
R1
2
R11 is not alkyl with direct chain; and when R3 is H then R4 is not C1-C6-alkyl. Synthesized compounds show antagonistic activity with respect to corticotropin releasing factor and can be used for treatment of patients with stress and other sicknesses. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 7 cl, 4 dwg, 5 tbl, 24 ex